Shift in Body Mass Index Category and Associated Cardiometabolic Risk Factors: A Post Hoc Analysis from the SURMOUNT-4 Trial

Diabetologie und Stoffwechsel 2025; 20(S 01): S99-S100
DOI: 10.1055/s-0045-1807556

Abstracts | DDG 2025

Poster

Posterwalk 15: Sonstige Themen

Authors

N Sattar

¹University of Glasgow, Diabetes and Obesity, Glasgow, United Kingdom
R Srinath

²Icahn School of Medicine at Mount Sinai, Diabetes and Obesity, New York, NY, United States
C J Lee

³Eli Lilly and Company, Diabetes and Obesity, Indianapolis, IN, United States
H Wang

⁴TechData Service Company, Diabetes and Obesity, King of Prussia, PA, United States
A Plat

³Eli Lilly and Company, Diabetes and Obesity, Indianapolis, IN, United States
M Blüher

⁵Universität Leipzig, Diabetes and Obesity, Leipzig, Germany
H Brinkmann

⁵Lilly Deutschland GmbH